BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update
- Tuesday, November 30, 2021, 7:06
- Finance
- Add a comment
JERUSALEM, Nov. 30, 2021 /PRNewswire/ — BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today published its third quarter…
About the Author
adminasapcorp has written 38936 stories on this site.